Envestnet Asset Management Inc I Mab Transaction History
Envestnet Asset Management Inc
- $324 Billion
- Q3 2025
Shares
2 transactions
Others Institutions Holding IMAB
# of Institutions
41Shares Held
15.5MCall Options Held
10.2KPut Options Held
0-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$28.1 Million0.6% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC4.17MShares$19.6 Million3.04% of portfolio
-
Ariose Capital Management LTD Central, Hong Kong, K31.7MShares$8.01 Million2.68% of portfolio
-
Candriam S.C.A.1.13MShares$5.32 Million0.02% of portfolio
-
Sg Americas Securities, LLC464KShares$2.18 Million0.01% of portfolio
About I-Mab
- Ticker IMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,098,800
- Market Cap $391M
- Description
- I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...